Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study

Overview of attention for article published in BMC Infectious Diseases, April 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 11 public wall posts from 10 users.

Benefits using the 13-valent pneumococcal conjugate vaccine (PCV13) in adults are controversial. This study investigated…

Pneumonia vaccine not only failed to prevent pneumococcal pneumonia, it made people more susceptible to pneumonia of other…

Did you know that the pneumonia vaccine may not be effective in preventing pneumonia, and may increase the risk of pneumonia? “P…

Did you know that the pneumonia vaccine may not be effective in preventing pneumonia, and may increase the risk of pneumonia? “P…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity, including 7 additional Facebook posts.